The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...

WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...

Botulinum toxin has come a long way since it was first used to treat strabismus (an eye misalignment) and later approved for ...

Infections, including influenza, COVID-19, HIV, hepatitis C and herpes zoster, can raise the risk of cardiovascular disease (CVD), and vaccines could help lower that risk, according to a study ...

The health benefit cost per employee is expected to increase 6.7% in 2026, rising from $17,496 per employee in 2025 to more than $18,500 next year, according to Mercer’s 2025 National Survey of ...

Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.

In this latest episode of his “Perry and Friends” podcast, Perry Cohen, Pharm.D., a member of the Managed Healthcare ...

A new study suggests epigenetic changes at Type 1 diabetes susceptibility genes may explain the risk profile of children born ...

Their study has discovered that subtle changes in lung scarring over just one year, as measured by quantitative computed tomography imaging, are strongly linked to future lung-function decline and ...

The FDA has approved a new type of medication to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare disease that causes extremely high triglycerides.

Expert discusses how, despite its importance, albuminuria screening remains underutilized, and improving adherence to dual ...

According to Mark Nestor, M.D., Ph.D., shared with MHE that injecting botulinum toxin in the glabella changes how the amygdala works and stops the brain from getting feedback from frowning, creating a ...